Neuro-ophthalmology of mitochondrial diseases

Polymorphism in mitochondrial DNA necessitates careful scrutiny of potentially pathogenic mutations to establish their true pathogenic significance. Research on Leber hereditary optic neuropathy continues to provide insights into the pathogenesis of mitochondrial disease. Interest in the retinal manifestations of mitochondrial disease has highlighted the macular dystrophy of the 3243 mutation, particularly in association with the syndrome of maternally inherited diabetes and deafness. Mitochondrial encephalopathies present in a number of ways, but imaging predominantly shows abnormalities of myelin and grey-matter nuclei. The mitochondrial myopathies provide insights into interactions between nuclear and mitochondrial DNA mutations and parallels between mitochondrial diseases and aging.

[1]  A. Hattersley,et al.  Pigmentary retinal dystrophy and the syndrome of maternally inherited diabetes and deafness caused by the mitochondrial DNA 3243 tRNA(Leu) A to G mutation. , 1999, Ophthalmology.

[2]  H. Thieme,et al.  A pedigree of Leber’s hereditary optic neuropathy with visual loss in childhood, primarily in girls , 1999, Graefe's Archive for Clinical and Experimental Ophthalmology.

[3]  E. Zrenner,et al.  Leber’s hereditary optic neuropathy: clinical and molecular genetic findings in a patient with a new mutation in the ND6 gene , 1999, Graefe's Archive for Clinical and Experimental Ophthalmology.

[4]  L. Went.  Leber hereditary optic neuropathy (LHON): a mitochondrial disease with unresolved complexities , 1999, Cytogenetic and Genome Research.

[5]  N. Newman,et al.  Optic nerve enhancement on orbital magnetic resonance imaging in Leber's hereditary optic neuropathy. , 1999, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[6]  H. Gin,et al.  Prevalence of macular pattern dystrophy in maternally inherited diabetes and deafness. GEDIAM Group. , 1999, Ophthalmology.

[7]  D. Beeson,et al.  Mapping of autosomal dominant progressive external ophthalmoplegia to a 7-cM critical region on 10q24 , 1999, Neurology.

[8]  S. Terae,et al.  MRI of the brain in the Kearns- Sayre syndrome: report of four cases and a review , 1999, Neuroradiology.

[9]  J. Shallo-Hoffmann,et al.  Comparing pupil function with visual function in patients with Leber's hereditary optic neuropathy. , 1999, Investigative ophthalmology & visual science.

[10]  D. Turnbull,et al.  Mitochondrial DNA analysis: polymorphisms and pathogenicity , 1999, Journal of medical genetics.

[11]  N. Newman,et al.  Retinopathy of NARP syndrome. , 2000, Archives of ophthalmology.

[12]  E. Holme,et al.  Autosomal dominant progressive external ophthalmoplegia , 1999, Neurology.

[13]  T. Yoshitomi,et al.  Comparison of threshold visual perimetry and objective pupil perimetry in clinical patients. , 1999, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[14]  J. Arenas,et al.  Mitochondrial diseases in children: neuroradiological and clinical features in 17 patients , 1999, Neuroradiology.

[15]  K. Bartz-Schmidt,et al.  Late onset of Leber’s hereditary optic neuropathy in HIV infection , 1999, The British journal of ophthalmology.

[16]  I. Nelson,et al.  The mitochondrial DNA G13513A transition in ND5 is associated with a LHON/MELAS overlap syndrome and may be a frequent cause of MELAS , 1999, Annals of neurology.

[17]  M. Malkoff,et al.  Mitochondrial maculopathy: geographic atrophy of the macula in the MELAS associated A to G 3243 mitochondrial DNA point mutation. , 1999, American journal of ophthalmology.

[18]  E. Shoubridge,et al.  Predominance of the T14484C mutation in French-Canadian families with Leber hereditary optic neuropathy is due to a founder effect. , 2000, American journal of human genetics.

[19]  J. García-Lozano,et al.  A new mitochondrial DNA mutation in the tRNA leucine 1 gene (C3275A) in a patient with Leber's hereditary optic neuropathy , 2000, Human mutation.

[20]  D. Turnbull,et al.  Evaluation of bupivacaine-induced muscle regeneration in the treatment of ptosis in patients with chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome , 1999, Eye.